摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,4-Dimethyl-2-(trifluoromethoxy)benzene | 1404194-52-0

中文名称
——
中文别名
——
英文名称
1,4-Dimethyl-2-(trifluoromethoxy)benzene
英文别名
——
1,4-Dimethyl-2-(trifluoromethoxy)benzene化学式
CAS
1404194-52-0
化学式
C9H9F3O
mdl
——
分子量
190.16
InChiKey
NHADAKHFDBNYAU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    参考文献:
    名称:
    使用 2,4-二硝基-1-(三氟甲氧基苯) 作为三氟甲氧基阴离子源进行芳烃的三氟甲氧基化
    摘要:
    芳烃的三氟甲氧基化在文献中报道很少,这主要是由于现有的稳定的三氟甲氧基阴离子源的数量有限。我们在此描述了使用 2,4-二硝基-1-(三氟甲氧基)苯 (DNTFB) 作为廉价且易于使用的 F 3 CO − 来源的芳烃的三氟甲氧基化。释放的三氟甲氧基阴离子既用作产生芳基的氟化物源,又用作三氟甲氧基化反应的亲核试剂。
    DOI:
    10.1002/ejoc.202400388
点击查看最新优质反应信息

文献信息

  • NOVEL IMMUNOMODULATOR AND ANTI-INFLAMMATORY COMPOUNDS
    申请人:MUTHUPPALANIAPPAN Meyyappan
    公开号:US20110275603A1
    公开(公告)日:2011-11-10
    The present invention provides dihydroorotate dehydrogenase inhibitors, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of diseases or disorders wherein the inhibition of Dihydroorotate dehydrogenase is known to show beneficial effect.
    本发明提供了脱氢鸟苷酸脱氢酶抑制剂,其制备方法,含有它们的药物组合物以及治疗、预防和/或改善疾病或障碍的方法,其中已知抑制脱氢鸟苷酸脱氢酶具有益处效果。
  • [EN] ISOINDOLINONE COMPOUNDS<br/>[FR] COMPOSÉS D'ISO-INDOLINONE
    申请人:MONTE ROSA THERAPEUTICS
    公开号:WO2021069705A1
    公开(公告)日:2021-04-15
    Disclosed herein is a compound or pharmaceutically acceptable salts or stereoisomers thereof of of formula I wherein X1 is linear or branched C1-6 alkyl, C3-6 cycloalkyl, -C1-6 alkyl C3-6 cycloalkyl, C6-10 aryl, 5-10 membered heteroaryl, C1-6 alkyl C6-10 aryl, C1-6 alkyl 5-10 membered heteroaryl, wherein X1 is unsubstituted or substituted with one or more of halogen, linear or branched C1-6 alkyl, linear or branched C1-6 heteroalkyl, CF3, CHF2, -O-CHF2, -O-(CH2)2-OMe, OCF3, C1-6 alkylamino, -CN, -N(H)C(O)-C1- 6alkyl, -OC(O)-C1-6alkyl, -OC(O)-C1-4alkylamino, -C(O)O-C1-6alkyl, -COOH, - CHO, -C1-6alkylC(O)OH, -C1-6alkylC(O)O-C1-6alkyl, NH2, C1-6 alkoxy or C1-6 alkylhydroxy; X2 is hydrogen, C6-10 aryl, 5-10 membered heteroaryl, -O-(5-10 membered heteroaryl), 4-8 membered heterocycloalkyl, C1-4 alkyl 4-8 membered heterocycloalkyl, -O-(4-8 membered heterocycloalkyl), -O-C1-4 alkyl-(4-8 membered heterocycloalkyl), -OC(O)-C1-4alkyl-4-8 membered heterocycloalkyl or C6 aryloxy, wherein X2 is unsubstituted or substituted with one or more of linear or branched C1-6 alkyl, NH2, NMe2 or 5-6 membered heterocycloalkyl; n is 0, 1 or 2.
    本公开涉及一种化合物或药用可接受盐或其立体异构体,其化学式为I,其中X1为直链或支链的C1-6烷基,C3-6环烷基,-C1-6烷基C3-6环烷基,C6-10芳基,5-10成员杂芳基,C1-6烷基C6-10芳基,C1-6烷基5-10成员杂芳基,其中X1未取代或取代为一个或多个卤素,直链或支链的C1-6烷基,直链或支链的C1-6杂烷基,CF3,CHF2,-O-CHF2,-O-(CH2)2-OMe,OCF3,C1-6烷基氨基,-CN,-N(H)C(O)-C1-6烷基,-OC(O)-C1-6烷基,-OC(O)-C1-4烷基氨基,-C(O)O-C1-6烷基,-COOH,-CHO,-C1-6烷基C(O)OH,-C1-6烷基C(O)O-C1-6烷基,NH2,C1-6烷氧基或C1-6烷基羟基;X2为氢,C6-10芳基,5-10成员杂芳基,-O-(5-10成员杂芳基),4-8成员杂环烷基,C1-4烷基4-8成员杂环烷基,-O-(4-8成员杂环烷基),-O-C1-4烷基-(4-8成员杂环烷基),-OC(O)-C1-4烷基-4-8成员杂环烷基或C6芳氧基,其中X2未取代或取代为一个或多个直链或支链的C1-6烷基,NH2,NMe2或5-6成员杂环烷基;n为0、1或2。
  • [EN] METHOD AND APPARATUS FOR THE SYNTHESIS OF DIHYDROARTEMISININ AND ARTEMISININ DERIVATIVES<br/>[FR] PROCÉDÉ ET APPAREIL DE SYNTHÈSE DE DIHYDROARTÉMISININE ET DE DÉRIVÉS D'ARTÉMISININE
    申请人:MAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V
    公开号:WO2015007693A1
    公开(公告)日:2015-01-22
    The present invention is directed to a method for continuous production of dihydroartemisinin and also artemisinin derivatives derived from dihydroartemisinin by using artemisinin or dihydroartemisinic acid (DHAA) as starting material as well as to a continuous flow reactor for producing dihydroartemisinin as well as the artemisinin derivatives. It was found that the reduction of artemisinin to dihydroartemisinin in a continuous process requires a special kind of reactor and a special combination of reagents comprising a hydride reducing agent, at least one activator such as an inorganic activator, at least one solid base, at least one aprotic solvent and at least one C1-C5 alcohol.
    本发明涉及一种连续生产二氢青蒿素以及由二氢青蒿素衍生的青蒿素衍生物的方法,该方法利用青蒿素或二氢青蒿酸(DHAA)作为起始物质,并且涉及一种用于生产二氢青蒿素以及青蒿素衍生物的连续流反应器。发现在连续过程中将青蒿素还原为二氢青蒿素需要一种特殊类型的反应器和一种特殊的试剂组合,包括一种氢化物还原剂,至少一种活化剂(例如无机活化剂),至少一种固体碱,至少一种无极性溶剂以及至少一种C1-C5醇。
  • [EN] ANTIMICROBIALS AND METHODS OF MAKING AND USING SAME<br/>[FR] ANTIMICROBIENS ET LEURS PROCÉDÉS DE PRÉPARATION ET D'UTILISATION
    申请人:MELINTA THERAPEUTICS INC
    公开号:WO2017193016A1
    公开(公告)日:2017-11-09
    The present disclosure relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, reducing the risk of, and delaying the onset of microbial infections in humans and animals. In some embodiments, the present disclosure provides a compound of Formula (I) or tautomer thereof or a pharmaceutically acceptable salt of the compound or tautomer.
    本公开涉及抗微生物化合物领域,以及制备和使用这些化合物的方法。这些化合物可用于治疗、预防、减少风险和延缓人类和动物的微生物感染的发生。在某些实施例中,本公开提供了化合物I的式或其互变异构体,或该化合物或互变异构体的药用可接受盐。
  • N-Phenyloxamide derivatives
    申请人:YAMAGUCHI Youichi
    公开号:US20080249175A1
    公开(公告)日:2008-10-09
    A compound represented by the following general formula (I) or a salt thereof, or a hydrate thereof or a solvate thereof having an inhibitory action against plasminogen activator inhibitor-1 (PAI-1): wherein R 1 represents a C 6-10 aryl group; or a C 6-10 aryl group substituted with a group or groups selected from the group consisting of a halogen atom, cyano group, nitro group, a C 1-6 alkyl group, a halogenated C 1-6 alkyl group, a C 1-6 alkoxy group, a halogenated C 1-6 alkoxy group and a C 1-6 alkylsulfanyl group, R 2 represents a C 6-10 aryl group; or a C 6-10 aryl group substituted with a group or groups selected from the group consisting of a halogen atom, hydroxy group, a C 1-6 alkyl group, a halogenated C 1-6 alkyl group, a C 1-6 alkoxy group, a halogenated C 1-6 alkoxy group, a C 1-6 alkylsulfanyl group and phenyl group, X represents a single bond or oxygen atom, Z represents a phenylene group or a substituted phenylene group, m represents 0 or 1.
    由以下一般式(I)表示的化合物或其盐,或其水合物或其溶剂合物,具有对纤溶酶原激活酶抑制剂-1(PAI-1)的抑制作用:其中R1表示一个C6-10芳基团;或一个C6-10芳基团,该芳基团取代为从卤原子、氰基、硝基、C1-6烷基、卤代C1-6烷基、C1-6烷氧基、卤代C1-6烷氧基和C1-6烷基硫基等组成的组或组合物,R2表示一个C6-10芳基团;或一个C6-10芳基团,该芳基团取代为从卤原子、羟基、C1-6烷基、卤代C1-6烷基、C1-6烷氧基、卤代C1-6烷氧基、C1-6烷基硫基和苯基等组成的组或组合物,X表示一个单键或氧原子,Z表示一个苯基或取代苯基,m表示0或1。
查看更多